Copyright Reports & Markets. All rights reserved.

Global Generic Active Pharmaceutical Ingredients Market Professional Survey Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Generic Active Pharmaceutical Ingredients

      • 1.1 Definition of Generic Active Pharmaceutical Ingredients
      • 1.2 Generic Active Pharmaceutical Ingredients Segment by Type
        • 1.2.1 Global Generic Active Pharmaceutical Ingredients Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Monoclonal Antibodies
        • 1.2.3 Hormones
        • 1.2.4 Cytokines
        • 1.2.5 Fusion Proteins
        • 1.2.6 Therapeutic Enzymes
        • 1.2.7 Vaccines
        • 1.2.8 Blood Factors
      • 1.3 Generic Active Pharmaceutical Ingredients Segment by Applications
        • 1.3.1 Global Generic Active Pharmaceutical Ingredients Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Diabetes
        • 1.3.4 Cardiovascular Disease
        • 1.3.5 CNS and Neurological Disorders
        • 1.3.6 Endocrinology
        • 1.3.7 Others
      • 1.4 Global Generic Active Pharmaceutical Ingredients Overall Market
        • 1.4.1 Global Generic Active Pharmaceutical Ingredients Revenue (2014-2025)
        • 1.4.2 Global Generic Active Pharmaceutical Ingredients Production (2014-2025)
        • 1.4.3 North America Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.4 Europe Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.5 China Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.6 Japan Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.8 India Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Generic Active Pharmaceutical Ingredients
      • 2.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients
      • 2.4 Industry Chain Structure of Generic Active Pharmaceutical Ingredients

      3 Development and Manufacturing Plants Analysis of Generic Active Pharmaceutical Ingredients

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Generic Active Pharmaceutical Ingredients Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Generic Active Pharmaceutical Ingredients
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Generic Active Pharmaceutical Ingredients Production and Capacity Analysis
      • 4.2 Generic Active Pharmaceutical Ingredients Revenue Analysis
      • 4.3 Generic Active Pharmaceutical Ingredients Price Analysis
      • 4.4 Market Concentration Degree

      5 Generic Active Pharmaceutical Ingredients Regional Market Analysis

      • 5.1 Generic Active Pharmaceutical Ingredients Production by Regions
        • 5.1.1 Global Generic Active Pharmaceutical Ingredients Production by Regions
        • 5.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Regions
      • 5.2 Generic Active Pharmaceutical Ingredients Consumption by Regions
      • 5.3 North America Generic Active Pharmaceutical Ingredients Market Analysis
        • 5.3.1 North America Generic Active Pharmaceutical Ingredients Production
        • 5.3.2 North America Generic Active Pharmaceutical Ingredients Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Generic Active Pharmaceutical Ingredients Import and Export
      • 5.4 Europe Generic Active Pharmaceutical Ingredients Market Analysis
        • 5.4.1 Europe Generic Active Pharmaceutical Ingredients Production
        • 5.4.2 Europe Generic Active Pharmaceutical Ingredients Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Generic Active Pharmaceutical Ingredients Import and Export
      • 5.5 China Generic Active Pharmaceutical Ingredients Market Analysis
        • 5.5.1 China Generic Active Pharmaceutical Ingredients Production
        • 5.5.2 China Generic Active Pharmaceutical Ingredients Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Generic Active Pharmaceutical Ingredients Import and Export
      • 5.6 Japan Generic Active Pharmaceutical Ingredients Market Analysis
        • 5.6.1 Japan Generic Active Pharmaceutical Ingredients Production
        • 5.6.2 Japan Generic Active Pharmaceutical Ingredients Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Generic Active Pharmaceutical Ingredients Import and Export
      • 5.7 Southeast Asia Generic Active Pharmaceutical Ingredients Market Analysis
        • 5.7.1 Southeast Asia Generic Active Pharmaceutical Ingredients Production
        • 5.7.2 Southeast Asia Generic Active Pharmaceutical Ingredients Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Generic Active Pharmaceutical Ingredients Import and Export
      • 5.8 India Generic Active Pharmaceutical Ingredients Market Analysis
        • 5.8.1 India Generic Active Pharmaceutical Ingredients Production
        • 5.8.2 India Generic Active Pharmaceutical Ingredients Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Generic Active Pharmaceutical Ingredients Import and Export

      6 Generic Active Pharmaceutical Ingredients Segment Market Analysis (by Type)

      • 6.1 Global Generic Active Pharmaceutical Ingredients Production by Type
      • 6.2 Global Generic Active Pharmaceutical Ingredients Revenue by Type
      • 6.3 Generic Active Pharmaceutical Ingredients Price by Type

      7 Generic Active Pharmaceutical Ingredients Segment Market Analysis (by Application)

      • 7.1 Global Generic Active Pharmaceutical Ingredients Consumption by Application
      • 7.2 Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)

      8 Generic Active Pharmaceutical Ingredients Major Manufacturers Analysis

      • 8.1 Pfizer, Inc. (U.S.)
        • 8.1.1 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.1.2 Pfizer, Inc. (U.S.) Product Introduction, Application and Specification
        • 8.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis International AG (Switzerland)
        • 8.2.1 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.2.2 Novartis International AG (Switzerland) Product Introduction, Application and Specification
        • 8.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi (France)
        • 8.3.1 Sanofi (France) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.3.2 Sanofi (France) Product Introduction, Application and Specification
        • 8.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Boehringer Ingelheim (Germany)
        • 8.4.1 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.4.2 Boehringer Ingelheim (Germany) Product Introduction, Application and Specification
        • 8.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Bristol-Myers Squibb (U.S.)
        • 8.5.1 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.5.2 Bristol-Myers Squibb (U.S.) Product Introduction, Application and Specification
        • 8.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Teva Pharmaceutical Industries Ltd. (Israel)
        • 8.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Product Introduction, Application and Specification
        • 8.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Eli Lilly and Company (U.S.)
        • 8.7.1 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.7.2 Eli Lilly and Company (U.S.) Product Introduction, Application and Specification
        • 8.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 GlaxoSmithKline plc (U.K.)
        • 8.8.1 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.8.2 GlaxoSmithKline plc (U.K.) Product Introduction, Application and Specification
        • 8.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Merck & Co., Inc. (U.S.)
        • 8.9.1 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.9.2 Merck & Co., Inc. (U.S.) Product Introduction, Application and Specification
        • 8.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 AbbVie Inc. (U.S.)
        • 8.10.1 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.10.2 AbbVie Inc. (U.S.) Product Introduction, Application and Specification
        • 8.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Generic Active Pharmaceutical Ingredients Market

      • 9.1 Global Generic Active Pharmaceutical Ingredients Market Trend Analysis
        • 9.1.1 Global Generic Active Pharmaceutical Ingredients Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Generic Active Pharmaceutical Ingredients Regional Market Trend
        • 9.2.1 North America Generic Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.2 Europe Generic Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.3 China Generic Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.4 Japan Generic Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.5 Southeast Asia Generic Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.6 India Generic Active Pharmaceutical Ingredients Forecast 2019-2025
      • 9.3 Generic Active Pharmaceutical Ingredients Market Trend (Product Type)
      • 9.4 Generic Active Pharmaceutical Ingredients Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Generic Active Pharmaceutical Ingredients Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Generic Active Pharmaceutical Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Generic Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Generic Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Generic Active Pharmaceutical Ingredients in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Generic Active Pharmaceutical Ingredients manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer, Inc. (U.S.)
        Novartis International AG (Switzerland)
        Sanofi (France)
        Boehringer Ingelheim (Germany)
        Bristol-Myers Squibb (U.S.)
        Teva Pharmaceutical Industries Ltd. (Israel)
        Eli Lilly and Company (U.S.)
        GlaxoSmithKline plc (U.K.)
        Merck & Co., Inc. (U.S.)
        AbbVie Inc. (U.S.)

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Monoclonal Antibodies
        Hormones
        Cytokines
        Fusion Proteins
        Therapeutic Enzymes
        Vaccines
        Blood Factors

        Segment by Application
        Oncology
        Diabetes
        Cardiovascular Disease
        CNS and Neurological Disorders
        Endocrinology
        Others

        Buy now